<p>Purified B cells were activated with 2 µg/ml anti-IgM, 20 U/ml IL-2 for 24, 48,72 and 96 h, in presence or absence of 100 ng/ml TL1A, stained with annexinV/PI and analyzed by flow cytometry. Analyses were gated on CD19-positive cells. (<b>A</b>) Dot plots representatives of three independent experiments. Bold numbers indicate percentage of cells in each quadrant. (<b>B</b>) Percentage of viable cells (annexinV-negative/PI-negative) following incubation with 2 µg/ml anti-IgM, 20 U/ml IL-2; 2 µg/ml anti-IgM, 20 U/ml IL-2, 100 ng/ml TL1A; medium. Data are represented as mean±SEM. * = <i>p</i><0.05; ns = not significant.</p
<p>(A) Structure of Lck inhibitor A-770041. (B) Percent of viable cells of LCL-WT, LCL-FLAG-LMP1 and...
<p>B cells were purified by depleting non-B cells resulting in >95% CD19<sup>+</sup> cells which sub...
<p>Purified CD19<sup>+</sup> B cells from SLE patients (n = 18) and healthy controls (n = 14) were c...
<p>(<b>A</b>) Representative flow cytometry histograms of CFSE-labeled B cells stimulated (empty cur...
<p>(<b>A</b>) Proliferating B cells were stimulated with different doses of anti-IgM antibodies (1, ...
<p>Data from a representative experiment (n = 2) on CD19, CD20, CD38, and CD138 expression in B cell...
Resting splenocyte cell suspensions were gated using the respective labeled antibody as a population...
<p>Wt mice were lethally irradiated and 24 hs later transplanted with wt or CTSL<i><sup>nkt/nkt</sup...
<p>Splenic T cells were isolated, purified, and activated with immobilized anti-CD3 antibody as desc...
<p>Purified PBLs were stimulated for 12 days with CD3/CD28 beads. After 12 days, beads were removed ...
<p>(A) BV2 cells were treated with the indicated doses of MCL for 24 h, then the cytotoxicity of MCL...
<p><b>A: Stimulation of human B cells with TLR ligands.</b> CFSE-labelled CD19+ human B cells were s...
<p>(A) Splenic B-cells obtained from <i>TAGLN2</i><sup><i>+/+</i></sup> and <i>TAGLN2</i><sup><i>-/-...
<p>(A-C) Analysis of BM and spleen cells from mice with advanced MLL/AF9-OVA leukemia (A) Flow-cytom...
<p>Purified PBLs were stimulated for 12 days with CD3/CD28 beads. After 12 days, beads were removed ...
<p>(A) Structure of Lck inhibitor A-770041. (B) Percent of viable cells of LCL-WT, LCL-FLAG-LMP1 and...
<p>B cells were purified by depleting non-B cells resulting in >95% CD19<sup>+</sup> cells which sub...
<p>Purified CD19<sup>+</sup> B cells from SLE patients (n = 18) and healthy controls (n = 14) were c...
<p>(<b>A</b>) Representative flow cytometry histograms of CFSE-labeled B cells stimulated (empty cur...
<p>(<b>A</b>) Proliferating B cells were stimulated with different doses of anti-IgM antibodies (1, ...
<p>Data from a representative experiment (n = 2) on CD19, CD20, CD38, and CD138 expression in B cell...
Resting splenocyte cell suspensions were gated using the respective labeled antibody as a population...
<p>Wt mice were lethally irradiated and 24 hs later transplanted with wt or CTSL<i><sup>nkt/nkt</sup...
<p>Splenic T cells were isolated, purified, and activated with immobilized anti-CD3 antibody as desc...
<p>Purified PBLs were stimulated for 12 days with CD3/CD28 beads. After 12 days, beads were removed ...
<p>(A) BV2 cells were treated with the indicated doses of MCL for 24 h, then the cytotoxicity of MCL...
<p><b>A: Stimulation of human B cells with TLR ligands.</b> CFSE-labelled CD19+ human B cells were s...
<p>(A) Splenic B-cells obtained from <i>TAGLN2</i><sup><i>+/+</i></sup> and <i>TAGLN2</i><sup><i>-/-...
<p>(A-C) Analysis of BM and spleen cells from mice with advanced MLL/AF9-OVA leukemia (A) Flow-cytom...
<p>Purified PBLs were stimulated for 12 days with CD3/CD28 beads. After 12 days, beads were removed ...
<p>(A) Structure of Lck inhibitor A-770041. (B) Percent of viable cells of LCL-WT, LCL-FLAG-LMP1 and...
<p>B cells were purified by depleting non-B cells resulting in >95% CD19<sup>+</sup> cells which sub...
<p>Purified CD19<sup>+</sup> B cells from SLE patients (n = 18) and healthy controls (n = 14) were c...